Charlie Watts treated for throat cancer

NewsGuard 100/100 Score

The drummer for The Rolling Stones Charles Robert "Charlie" Watts is currently being treated for throat cancer. He is reported to be at the end of a six-week course of radiotherapy after being diagnosed in June of this year.

Formed in 1962, The Rolling Stones have become one of the world's most widely recognized and popular bands.

Cancer of the throat involves malignant tumors (growths) on the vocal cords, voice box (larynx), or other areas of the throat.

People who smoke or otherwise use tobacco are at risk of developing tumors of the throat. Excessive alcohol use also increases risk, and smoking and alcohol use together constitute an extreme risk for the development of throat cancers.

Most cancers of the throat develop in adults older than 50, and men are 10 times more likely than women to develop throat cancers.

Throat cancers can be cured in 90% of patients if detected early. If the cancer has spread to surrounding tissues or lymph nodes in the neck 50-60% of patients can be cured. If the cancer has spread (metastasized) to parts of the body outside the head and neck, the cancer is not curable and treatment is aimed at prolonging quality of life.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NCCN 2024 Annual Conference focuses on practical applications for improving cancer care